AlphaFold predicted structure
PTPRO · Q16827

Mean pLDDT
77.4/ 100
Confident
1,216 residues
Confidence breakdown
- Very high(≥ 90)33%
- Confident(70–90)42%
- Low(50–70)11%
- Very low(< 50)15%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
protein tyrosine phosphatase receptor type O
Annotations refreshed 1 month ago.
Moderate Evidence (Amber)
Proteinuric renal disease
Unexplained kidney failure in young people
familial idiopathic steroid-resistant nephrotic syndrome
neurodegenerative disease
nephrotic syndrome
Parkinson disease
endometriosis
Alzheimer disease
multiple sclerosis
lysosomal storage disease
hypertensive disorder
intelligence
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Receptor-type tyrosine-protein phosphatase U
Tyrosine-protein phosphatase which dephosphorylates CTNNB1. Regulates CTNNB1 function both in cell adhesion and signaling. May function in cell proliferation and migration and play a role in the maintenance of epithelial integrity. May play a role in megakaryocytopoiesis
Curated MONDO disease pages that list PTPRO among their top associated genes.
PTPRO · Q16827

Mean pLDDT
77.4/ 100
Confident
1,216 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0